Business
Press Release Nov 21 2024
Natco Pharma Limited has informed the Exchange regarding a press release dated November 21, 2024, titled "The Company has submitted the Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Risdiplam for Oral Solution".
About this update from Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated November 21, 2024, titled "The Company has submitted the Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Risdiplam for Oral Solution". View Attachment
View stock analysis, news, and events for Natco Pharma Limited